PL371725A1 - Tłuszcz triglicerydowy - Google Patents

Tłuszcz triglicerydowy

Info

Publication number
PL371725A1
PL371725A1 PL03371725A PL37172503A PL371725A1 PL 371725 A1 PL371725 A1 PL 371725A1 PL 03371725 A PL03371725 A PL 03371725A PL 37172503 A PL37172503 A PL 37172503A PL 371725 A1 PL371725 A1 PL 371725A1
Authority
PL
Poland
Prior art keywords
triglycerides
weight
fat
fatty acid
carbon atoms
Prior art date
Application number
PL03371725A
Other languages
English (en)
Other versions
PL205287B1 (pl
Inventor
Eckhard Floeter
Original Assignee
Unilever N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever N.V. filed Critical Unilever N.V.
Publication of PL371725A1 publication Critical patent/PL371725A1/pl
Publication of PL205287B1 publication Critical patent/PL205287B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
    • A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10—Ester interchange
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8775—Murine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

Przedstawiono tłuszcz odpowiedni jako faza tłuszczowa do wytwarzania niskotłuszczowych środków do smarowania (spreadów), które są trwałe w podwyższonych temperaturach otoczenia, który to tłuszcz zawiera mieszaninę triglicerydów, w których - 2,5% do 5,5% wagowych triglicerydów to triglicerydy HHH, - 25% do 65% wagowych, korzystnie 25% do 55 % wagowych triglicerydów HHH to monokwasowe triglicerydy a pozostałe triglicerydy HHH składają się z mieszanych reszt kwasów tłuszczowych, 1,5% do 5% wagowych triglicerydów to triglicerydy HHM i triglicerydy HMH, - co najmniej 85% wagowych reszt kwasu tłuszczowego H w triglicerydach HHM i triglicerydach HMH to reszty kwasu palmitynowego, gdzie H oznacza resztę nasyconego kwasu tłuszczowego mającego długość łańcucha większą niż 15 atomów węgla, a M oznacza resztę nasyconego kwasu tłuszczowego mającego długość łańcucha albo 12 albo 14 atomów węgla, i przy czym reszty M są umieszczone albo w środkowej albo w jednej ze skrajnych pozycji. Taką fazę tłuszczową można otrzymać przez wprowadzanie do triglicerydowego oleju tłuszczu A i tłuszczu B, gdzie tłuszcz A i tłuszcz B razem występują w ilości do 6% do 15% wagowych tłuszczu i w stosunku wagowym A/B mieszczącym się w zakresie 1/9 do 4/6, przy czym w tłuszczu A - co najmniej 50% wagowych triglicerydów jest całkowicie nasyconych, co najmniej 80% wagowych materiału stanowiącego reszty nasyconych kwasów tłuszczowych ma długość łańcucha wynoszącą 16 atomów węgla (P) albo 18 atomów węgla (S), a stosunek P:S mieści się w zakresie 75:25 do 25:75, - do 5% wagowych reszt nasyconych kwasów tłuszczowych ma długość łańcucha wynoszącą 12 albo 14 atomów węgla; a w tłuszczu B - co najmniej 20% wagowych, korzystnie co najmniej 25% wagowych triglicerydów składa się z triglicerydów HHM i triglicerydów HMH.
PL371725A 2002-04-09 2003-03-10 Tłuszcz trójglicerydowy, sposób jego wytwarzania, sposób wytwarzania jadalnego środka do smarowania zawierającego taki tłuszcz trójglicerydowy oraz jadalny środek do smarowania otrzymany tym sposobem PL205287B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02076376 2002-04-09

Publications (2)

Publication Number Publication Date
PL371725A1 true PL371725A1 (pl) 2005-06-27
PL205287B1 PL205287B1 (pl) 2010-03-31

Family

ID=28685931

Family Applications (1)

Application Number Title Priority Date Filing Date
PL371725A PL205287B1 (pl) 2002-04-09 2003-03-10 Tłuszcz trójglicerydowy, sposób jego wytwarzania, sposób wytwarzania jadalnego środka do smarowania zawierającego taki tłuszcz trójglicerydowy oraz jadalny środek do smarowania otrzymany tym sposobem

Country Status (12)

Country Link
US (1) US7524524B2 (pl)
EP (1) EP1492410B1 (pl)
AT (1) ATE457649T1 (pl)
AU (1) AU2003218752B2 (pl)
BR (1) BR0308747B1 (pl)
CA (1) CA2481700C (pl)
DE (1) DE60331298D1 (pl)
MX (1) MXPA04009732A (pl)
PL (1) PL205287B1 (pl)
RU (1) RU2307517C2 (pl)
WO (1) WO2003084337A1 (pl)
ZA (1) ZA200407149B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6388113B1 (en) 1999-06-04 2002-05-14 Consejo Superior De Investigaciones Cientificas ( Csic) High oleic/high stearic sunflower oils
MXPA05001630A (es) * 2002-08-12 2005-04-25 Unilever Nv Grasa de trigliceridos.
US8025913B2 (en) 2003-07-17 2011-09-27 Conopco Inc. Process for the preparation of an edible dispersion comprising oil and structuring agent
GB0409156D0 (en) * 2004-04-24 2004-05-26 Haye Pierre A procedure to manufacture a texturized, thermo-resistant and thermo-irreversible gel composed of vegetable and/or animal fats and the product made with this
BRPI0606151A8 (pt) 2005-01-28 2017-09-19 Unilever Nv Dispersão entornável comestível e processo para a preparação de uma dispersão comestível contendo gordura
WO2006087093A1 (en) 2005-02-17 2006-08-24 Unilever N.V. Process for the preparation of a spreadable dispersion comprising sterol
US10757953B2 (en) 2005-09-26 2020-09-01 Upfield Europe B.V. Non-hydrogenated hardstock fat
US8431177B2 (en) * 2007-08-02 2013-04-30 Bunge Oils, Inc. Shortenings and methods of making and using thereof
BRPI0822194A2 (pt) * 2008-01-10 2014-10-07 Aceites Y Grasas Vegetales S A Acegrasas S A Produto graxo com baixo conteúdo de gordura saturada e livre de ácidos graxos trans
CA2727090C (en) * 2008-06-11 2017-06-06 General Mills Marketing, Inc. Hydrated fat piece compositions and dough articles made therefrom
EP2367435A1 (en) * 2008-12-19 2011-09-28 Unilever NV Edible fat powders
PL2367434T3 (pl) 2008-12-19 2017-09-29 Unilever BCS Europe B.V. Jadalne tłuszczowe proszki
EA024216B1 (ru) 2010-06-22 2016-08-31 Юнилевер Н.В. Порошкообразные пищевые жиры
MX342040B (es) 2010-12-17 2016-09-12 Unilever Nv Emulsion de agua en aceite comestible.
WO2012079955A1 (en) 2010-12-17 2012-06-21 Unilever Nv Process of compacting a microporous fat powder and compacted fat powder so obtained
WO2012154413A1 (en) 2011-05-09 2012-11-15 General Mills, Inc. Fat compositions and related methods, including shortening particles and shortening compositions without added non-interesterified hardstock fat, and related products
EP2710898B1 (en) * 2011-05-17 2017-07-05 The Nisshin OilliO Group, Ltd. Oil or fat composition which can be used as non-tempered hard butter
EP2840899B1 (en) 2012-04-27 2016-09-14 General Mills, Inc. Fat particle compositions containing salt, dough and baked dough articles made therefrom, and related methods
EP2692238A1 (en) * 2012-08-03 2014-02-05 Bunge Növényolajipari Zártköruen Muködo Részvénytársasag New fat blend composition
EP3270704A1 (en) 2015-03-18 2018-01-24 Cargill, Incorporated Low-fat water-in-oil emulsion
CN111378534B (zh) * 2018-12-27 2022-11-25 丰益(上海)生物技术研发中心有限公司 结构酯组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1107206A (en) * 1964-12-28 1968-03-27 Nat Biscuit Co Hard butter and chocolate coating composition containing same
DE3360419D1 (en) 1982-03-12 1985-08-29 Unilever Nv Margarine fat blend, and a process for producing said fat blend
GB8432058D0 (en) * 1984-12-19 1985-01-30 Unilever Plc Edible fat
ATE110935T1 (de) * 1990-08-02 1994-09-15 Unilever Nv Verbesserung essbarer fette.
ES2072085T3 (es) 1991-07-03 1995-07-01 Unilever Nv Composiciones de chocolate mejoradas.
US5470598A (en) * 1994-03-23 1995-11-28 The Procter & Gamble Company Beta-prime stable low-saturate, low trans, all purpose shortening
US6238926B1 (en) * 1997-09-17 2001-05-29 Cargilll, Incorporated Partial interesterification of triacylglycerols
GB2350618A (en) * 1999-06-01 2000-12-06 Danisco Shortening systems comprising a non-hydrogenated vegetable oil and either a stearine fraction or a saturated fatty acid diglyceride

Also Published As

Publication number Publication date
AU2003218752B2 (en) 2006-12-07
EP1492410B1 (en) 2010-02-17
DE60331298D1 (de) 2010-04-01
PL205287B1 (pl) 2010-03-31
ATE457649T1 (de) 2010-03-15
BR0308747A (pt) 2005-01-11
CA2481700A1 (en) 2003-10-16
AU2003218752A1 (en) 2003-10-20
WO2003084337A1 (en) 2003-10-16
CA2481700C (en) 2012-10-09
US7524524B2 (en) 2009-04-28
RU2004132825A (ru) 2005-06-10
EP1492410A1 (en) 2005-01-05
ZA200407149B (en) 2006-02-22
RU2307517C2 (ru) 2007-10-10
BR0308747B1 (pt) 2013-12-17
MXPA04009732A (es) 2005-01-11
US20050220965A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
PL371725A1 (pl) Tłuszcz triglicerydowy
DK1839493T3 (da) Oliesammensætning af konjugeret linolsyre
US8404003B2 (en) Vegetable lipid-based composition and candle
DK1682226T3 (da) Lipidpræparat til forbedring af mineralabsorption
ATE106672T1 (de) Salatöl, nützlich für die gesundheit.
US20070006522A1 (en) Vegetable lipid-based composition and candle
ATE423833T1 (de) Nichthydrierte fettzusammensetzung und verwendung davon
ATE551908T1 (de) Triglyceridfett
EP1961312A3 (en) Microbial oil mixture and uses thereof
MY112601A (en) Fat blend for margarine and w/o spreads
DK1290119T3 (da) Fremstilling af en blanding af triglycerider
PL2104727T3 (pl) Sztuczne polano z zastosowaniem nienaftowych wosków
ATE201961T1 (de) An polyungesättigten fettsäuren reiche triglyceride
WO2007078311A3 (en) Non-hydrogenated vegetable oil based margarine
HUP0402214A2 (hu) Önthető zsírdiszperziók
EP1965652A4 (en) REDUCTION BASED ON NON-HYDROGENIZED PLANT OIL BY USING AN INCREASED DIGLYCERIN EMULSIFIER COMPOSITION
MY134678A (en) A process for obtaining an oil composition and the oil composition obtained therefrom
NO884237D0 (no) Hydrauliske fluida.
BR0307985A (pt) Gordura de triglicerìdeos, seu processo de preparação, composição alimentìcia e espalhante de emulsão contìnua de gordura
DK0879274T3 (da) Tekniske di- og triglyceridblandinger
WO2006134355A3 (en) Gas-generating additives having improved shelf lives for use in cement compositions, and associated methods
MY182828A (en) Fuel lubricity additive
MY166544A (en) The palm based oil composition for achieving cold stability